Next Article in Journal
miR-22 Modulates Lenalidomide Activity by Counteracting MYC Addiction in Multiple Myeloma
Next Article in Special Issue
Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia
Previous Article in Journal
Genetic Alterations and Resectability Predict Outcome in Patients with Neuroblastoma Assigned to High-Risk Solely by MYCN Amplification
Previous Article in Special Issue
LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia
 
 
Review

Article Versions Notes

Cancers 2021, 13(17), 4364; https://doi.org/10.3390/cancers13174364
Action Date Notes Link
article xml file uploaded 28 August 2021 15:58 CEST Original file -
article xml uploaded. 28 August 2021 15:58 CEST Update -
article pdf uploaded. 28 August 2021 15:58 CEST Version of Record https://www.mdpi.com/2072-6694/13/17/4364/pdf-vor
article html file updated 28 August 2021 16:00 CEST Original file -
article xml file uploaded 30 August 2021 15:12 CEST Update -
article xml uploaded. 30 August 2021 15:12 CEST Update https://www.mdpi.com/2072-6694/13/17/4364/xml
article pdf uploaded. 30 August 2021 15:12 CEST Updated version of record https://www.mdpi.com/2072-6694/13/17/4364/pdf
article html file updated 30 August 2021 15:14 CEST Update -
article html file updated 30 July 2022 03:13 CEST Update https://www.mdpi.com/2072-6694/13/17/4364/html
Back to TopTop